İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

BERKANT KURBAN

ARAŞTIRMA GÖREVLİSİ

AFYONKARAHİSAR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 13
  • Proje 0
  • Kitap 0
  • Bildiri 5
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 8 Q2 2 Q3 4 Q4 0
WoS (JCR) Q1 3 Q2 7 Q3 4 Q4 0
TR Index 0 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 4
Ort. yüzdelik 68.2%
Üst %1 payı 0.0%
Üst %10 payı 30.8%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 13 yayın

Scopus (SJR)
Q1 8 Q2 2 Q3 4 Q4 0
WoS (JCR)
Q1 3 Q2 7 Q3 4 Q4 0
TR Index
0 makale

Makale listesi

  1. 2026 Novel thiadiazole derivatives: synthesis, in silico, in vitro and in vivo evaluation of analgesic and anti-inflammatory activities Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.109565 YÖKSİS SJR Q1 JCR Q1 OpenAlex 6.8%
  2. 2026 Design, Synthesis and Biological Effects Studies of Novel EGFR Inhibitors Targeting Wild-Type and Mutant EGFR (EGFR-L858R and EGFR-L858R/T790M) ACS Omega DOI 10.1021/acsomega.6c00728 YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.8%
  3. 2026 Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment RSC MEDICINAL CHEMISTRY DOI 10.1039/d6md00165c YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 94.1%
  4. 2026 Novel pyridazinone-based N-phenylacetamides as α-glucosidase-selective and dual α-glucosidase/aldose reductase inhibitors: Synthesis, SAR analysis, and cytotoxicity evaluation Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.110061 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.7%
  5. 2025 Latest developments in small molecule analgesics: heterocyclic scaffolds II Future Medicinal Chemistry DOI 10.1080/17568919.2025.2559570 YÖKSİS SJR Q3 JCR Q3 OpenAlex 81.2%
  6. 2025 In vivo evaluation of the antinociceptive effects of novel methylsulfonyl group-containing compounds Zeitschrift für Naturforschung C DOI 10.1515/znc-2024-0210 YÖKSİS SJR Q3 JCR Q3 OpenAlex 2.7%
  7. 2025 Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes Polycyclic Aromatic Compounds DOI 10.1080/10406638.2024.2442581 YÖKSİS SJR Q3 JCR Q2 OpenAlex 21.6%
  8. 2025 Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors RSC Advances DOI 10.1039/D5RA05397H YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.1%
  9. 2024 Investigation of dual AChE/MAO inhibitory activities of new morpholine and piperazine structured compounds European Journal of Life Sciences DOI 10.55971/EJLS.1497639 YÖKSİS OpenAlex 85.2%
  10. 2023 Synthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors ACS OMEGA DOI 10.1021/acsomega.3c04635 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 95.8%
  11. 2023 Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies CHEMISTRY & BIODIVERSITY DOI 10.1002/cbdv.202300944 YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.6%
  12. 2022 Design, synthesis, molecular docking and molecular dynamics studies of novel triazolothiadiazine derivatives containing furan or thiophene rings as anticancer agents. Bioorganic chemistry DOI 10.1016/j.bioorg.2022.105709 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.6%
  13. 2021 Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors. Molecules (Basel, Switzerland) DOI 10.3390/molecules26216640 YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.3%

Akademisyenlere dön